Spyre Therapeutics, LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2013-01-01
- Employees
- 101
- Market Cap
- $1.4B
- Website
- http://www.spyre.com
SPY003-207 in Health Volunteers
Phase 1
Recruiting
- Conditions
- Healthy
- Interventions
- Drug: SPY003-207Other: Placebo
- First Posted Date
- 2025-03-13
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Spyre Therapeutics, Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT06873724
- Locations
- 🇨🇦
Spyre Site 1, Montréal, Quebec, Canada
A Study of SPY002-091 in Healthy Volunteers
- First Posted Date
- 2024-11-04
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Spyre Therapeutics, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT06672718
- Locations
- 🇺🇸
Spyre Site 1, Cypress, California, United States
A Study of SPY002-072 in Healthy Volunteers
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Spyre Therapeutics, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT06622070
- Locations
- 🇺🇸
Spyre Site 2, Cypress, California, United States
🇨🇦Spyre Site 1, Montréal, Quebec, Canada
A Study of SPY001-001 in Healthy Volunteers
- First Posted Date
- 2024-06-07
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Spyre Therapeutics, Inc.
- Target Recruit Count
- 96
- Registration Number
- NCT06448247
- Locations
- 🇺🇸
Spyre Site 2, Cypress, California, United States
🇨🇦Spyre Site 1, Montréal, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath